INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,558 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
PB
Patadia Ankit B.EVP and Treasurer
DOCHEALTHPEAK PROPERTIES, INC.
Grant or award
A—
1,079 sh
Jan 28, 2026Jan 30, 2026
Page 1401 of 1814
← PrevNext →
traded Jan 28, 2026
+2d
SEC Form 4

Evidence

9
HC
Hicks Ken CDirector
ASOAcademy Sports & Outdoors, Inc.
Option exercise
M—
1,245 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
CS
Cullen SusanSEVP/CFO
FFICFLUSHING FINANCIAL CORP
Tax withholding
F$7,459
480 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,887 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
CA
Caldwell Christopher ADirector, President and CEO
CNXCConcentrix Corp
Tax withholding
F$44K
1,210 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$365K
3,071 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Derivative conversion
C—
64.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,750 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
WE
Whaley Keith EdwardDirector
SMBKSMARTFINANCIAL INC.
Grant or award
A—
808 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,000 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
AA
Alonso Lisa AEVP and Chief HR Officer
DOCHEALTHPEAK PROPERTIES, INC.
Tax withholding
F$4,463
252 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,000 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
BT
Bedrick ToddSVP, CAO
ABSIAbsci Corp
Grant or award
A—
59.4K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,859 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
RJ
Russo Joseph J.EVP&Pres-Global Networks&Tech
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,104
97 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
ML
Merendino LaurenChief Commercial Officer
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
110.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Derivative conversion
C—
291.5K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Derivative conversion
C—
214.8K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
RK
Ratzan Brian K.Director
SMPLSimply Good Foods Co
Grant or award
A—
6,500 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
MG
Mabry Adam GCIO
DOCHEALTHPEAK PROPERTIES, INC.
Grant or award
A—
2,156 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
BL
Barrett Victor LynnDirector
SMBKSMARTFINANCIAL INC.
Grant or award
A—
808 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
SK
Slupkowski KrzysztofChief Credit Officer
EQBKEQUITY BANCSHARES INC
Tax withholding
F$2,485
55 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
PA
Porter Tracy AEVP and General Counsel
DOCHEALTHPEAK PROPERTIES, INC.
Grant or award
A—
11.3K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
LP
Lawrence Steven PaulDirector, CEO
ASOAcademy Sports & Outdoors, Inc.
Tax withholding
F$46K
839 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$299K
2,500 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
237.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$141K
1,200 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$141K
1,200 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$65K
543 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$65K
543 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

5
BM
Brosius MarkSVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Grant or award
A—
2,702 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

5
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
1,925 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

5
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
18.1K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

5
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
20.0K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

5
TJ
Twomey Cormac JEVP, Global Ops & Delivery
CNXCConcentrix Corp
Tax withholding
F$8,390
231 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

5
TB
Tucker Steven B.Director
SMBKSMARTFINANCIAL INC.
Grant or award
A—
808 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

5
TJ
Twomey Cormac JEVP, Global Ops & Delivery
CNXCConcentrix Corp
Grant or award
A—
491 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

5
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M$55.8
90 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

5
BM
Brosius MarkSVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Grant or award
A—
5,585 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

5
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
11.8K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence